Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/15/2005US20050202021 Anti-cancer antibodies with reduced complement fixation
09/15/2005US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
09/15/2005US20050202017 Assay; contacting a test compound with a HB-954 polypeptide; determining whether the test compound binds to the G protein-coupled receptor
09/15/2005US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050202009 Novel MHC II associated peptides
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050202000 Polymerizing ability and cellular and humoral immunogenicity decreased as compared with the wild the wild-type staphylokinase; Mutant genes were constructed by PCR site-directed mutagenesis, then recombined with a prokaryotic vector and used to transform E. coli.; thrombolytics and anticoagulant
09/15/2005US20050201994 Administering a human sequence antibody that specifically binds to human Cytotoxic T-lymphocyte-associated protein 4; anticarcinogenic, antitumor
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201985 Modified adenoviral vectors for use in vaccines and gene therapy
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201983 Capsid and capsid-expressing genome modified to display heterologous peptide(s) to allow nuclear or subcellular targeting by delivering a peptide into the cell nucleus; easy construction of libraries using site-specific recombination in vitro; peptide/protein fusion with capsid protein vp39 (AcMNPV)
09/15/2005US20050201979 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201975 Modifying chemokine G-protein mediated signalling and/or signal transduction by administering a modulator of the Notch signalling pathway; using a fusion protein of a segment of a Notch ligand extracellular domain and an immunoglobulin Fc segment or a polynucleotide encoding it; antiinflammatory agents
09/15/2005US20050201973 Therapeutic supramolecules
09/15/2005US20050201936 Adenoviral gene therapy; examination of the ability of various replicative, non-replicative and conditionally-replicative adenovirus vectors to treat cancer
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005US20050201481 Method and apparatus for data transmission using multiple transmit antennas
09/15/2005DE102004009453A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von coryneformen Bakterien A method for producing L-amino acids using coryneform bacteria
09/15/2005DE102004009018A1 Verfahren zur Modulation Gibberellinsäure-abhängiger Prozesse in Pflanzen A method of modulating gibberellin-dependent processes in plants
09/15/2005DE102004007624A1 Preparation of ketocarotenoids, useful in foods and animal feeds, by growing genetically modified organism, particularly plant, having altered ketolase activity
09/15/2005CA2812132A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2598687A1 Flavonoids
09/15/2005CA2566307A1 Canine ghrh gene, polypeptides and methods of use
09/15/2005CA2563397A1 Adzymes and uses thereof
09/15/2005CA2560066A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2559114A1 Compounds for hydrolysing ribonucleic acids (rnas)
09/15/2005CA2558960A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
09/15/2005CA2558839A1 Plants having improved yield and method for making the same
09/15/2005CA2558667A1 Antisense oligonucleotides for inhibiting the formation of metastases in cancer
09/15/2005CA2558660A1 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
09/15/2005CA2558656A1 Insecticidal toxin complex fusion proteins
09/15/2005CA2558593A1 .beta.-fructofuranosidase variants
09/15/2005CA2558586A1 Recombinant varicella-zoster virus
09/15/2005CA2558515A1 Method of enriching and/or separating prokaryotic dna by means of a protein which specifically binds dna containing non-methylated cpg motifs
09/15/2005CA2558436A1 Method of proliferating precursor cells
09/15/2005CA2558262A1 Rnai-based therapeutics for allergic rhinitis and asthma
09/15/2005CA2558152A1 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids
09/15/2005CA2558084A1 Method of modifying plant seeds comprising modulating expression of mint transcription factor
09/15/2005CA2557953A1 Preparation of recombinant rotavirus proteins in milk of transgenic non human mammals
09/15/2005CA2557854A1 Method for improving productivity of plant by chloroplast technology
09/15/2005CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment
09/15/2005CA2557788A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005CA2557761A1 Method of detecting carcinogenesis caused by hepatitis b virus
09/15/2005CA2557661A1 Nucleic acid complexes
09/15/2005CA2557418A1 Stomatal guard cell specific promoter
09/15/2005CA2555976A1 Method for producing polyhydroxyalkanoate
09/15/2005CA2554966A1 Methods and compostions for targeted cleavage and recombination
09/15/2005CA2553734A1 Rna-dependent dna polymerase from geobacillus stearothermophilus
09/14/2005EP1574586A2 Method and apparatus for amplifying nucleic acids
09/14/2005EP1574583A1 Methods for isolation of bacteria from biological samples
09/14/2005EP1574580A2 Transgenic plants expressing cellulolytic enzymes
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574575A1 GLUCOSE AND/OR FRUCTOSE TRANSPORTER NaGLT1 AND ITS GENE
09/14/2005EP1574574A1 Exon 1-beta of pdgf receptor alpha gene and utilization thereof
09/14/2005EP1574573A2 Compositions and methods for genetic modification of plants
09/14/2005EP1574572A1 Compounds for hydrolysing ribonucleic acids (RNAs)
09/14/2005EP1574571A1 Germ-responsive promoter
09/14/2005EP1574570A1 Process for reducing the number of mismatches in double stranded polynucleotides
09/14/2005EP1574569A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same
09/14/2005EP1574566A1 A microbial process for arginine production
09/14/2005EP1574565A1 Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same
09/14/2005EP1574519A1 Transcription control factor ZHX3
09/14/2005EP1574518A2 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof
09/14/2005EP1573636A2 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
09/14/2005EP1573322A2 METHODS OF SCREENING FOR TRPM4b MODULATORS
09/14/2005EP1573314A2 Transgenic mice expressing human cd20
09/14/2005EP1573313A2 Transgenic mice expressing human cd20 and/or cd16
09/14/2005EP1573070A2 pRNA CHIMERA
09/14/2005EP1573060A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
09/14/2005EP1573058A1 A method for improving protein production
09/14/2005EP1573056A2 Methods for fragmentation, labeling and immobilization of nucleic acids
09/14/2005EP1573033A2 Animal genotyping method
09/14/2005EP1573031A2 Androgen regulated nucleic acid molecules and encoded proteins
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573016A2 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
09/14/2005EP1573015A1 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it
09/14/2005EP1573014A2 Immunization of fish with plant-expressed recombinant proteins
09/14/2005EP1573013A2 Parallel chromosomal stacking of traits in bacteria
09/14/2005EP1573012A1 Recombinant viral-based malaria vaccines
09/14/2005EP1573011A1 Method for preparing recombinant heterocarpine
09/14/2005EP1573010A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants
09/14/2005EP1573009A2 Detection of small nucleic acids
09/14/2005EP1573007A2 Method for chromosomal engineering
09/14/2005EP1573005A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
09/14/2005EP1573004A2 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
09/14/2005EP1573001A1 Yeast treatment
09/14/2005EP1573000A2 Crystal structure of glutamate racemase (muri)
09/14/2005EP1572998A2 Serine protease
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572993A2 Novel choline oxidases
09/14/2005EP1572986A1 Restoration of methylation states in cells
09/14/2005EP1572985A1 Production of alvac on avian embryonic stem cells
1 ... 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 ... 4023